Stay updated on Pembrolizumab in CAR T Failure Lymphomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.

Latest updates to the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page adds Revision: v3.4.2, and removes a government funding lapse notice and the older Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check41 days agoChange DetectedA government funding lapse notice now appears on the page, stating that information may not be up to date. The site version was updated to Revision: v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check48 days agoChange DetectedAdded a 'Show glossary' option and a new 'Revision: v3.4.0' label; minor metadata updates include capitalization changes for labels and removal of older entries. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange Detected- Page revision label updated from v3.3.3 to v3.3.4. This appears to be a versioning update and does not alter the study content on the page.SummaryDifference0.1%

- Check84 days agoChange DetectedA new Locations section appears for the Philadelphia, PA site under Pennsylvania, replacing the old Pennsylvania Locations entry. The footer revision has been updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in CAR T Failure Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.